Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Angela Russo

Angela Russo


Research Assistant Professor, Pharmaceutical Sciences

Related Sites:

Selected Grants

Characterization and targeting the markers of stemness altered during ovarian cancer pathogenesis using WNT inhibitors, Marsha Rivkin Center for Ovarian Cancer Research., 4/1/2018 - 9/30/2020, Obligated Amount: $75000; Anticipated Amount: $75000

Role of Intersectin-Regulated Sinaling Pathways in Neuroblastoma Turmorigenesis., St Baldrick's Foundation., 7/1/2012 - 6/30/2013, Obligated Amount: $117000; Anticipated Amount: $117000

Selected Publications

Russo, A, Zizhao, Y, Heyrman, GM, Cain, BP, Lopez Carrero, A, Isenberg, BC, Dean, MJ, Coppeta, J, Burdette, JE. (2022). Versican secreted by the ovary links ovulation and migration in fallopian tube derived serous cancer. Cancer Letters, 543. doi:10.1016/j.canlet.2022.215779.

Russo, A, Burdette, JE. (2022). Isolation of Fallopian Tube Epithelium for Assessment of Cilia Beating Frequency (CBF). Methods in Molecular Biology. (pp. 179-187). doi:10.1007/978-1-0716-1956-8_12.

Jackson-Bey, T, Colina, J, Isenberg, BC, Coppeta, J, Urbanek, M, Kim, JJ, Woodruff, TK, Burdette, JE, Russo, A. (2021). Reply: Exposure of human fallopian tube epithelium to elevated testosterone results in alteration of cilia gene expression and beating. Human Reproduction, 36, (6), 1725. doi:10.1093/humrep/deab022.

Russo, A, Colina, JA, Moy, J, Baligod, S, Czarnecki, AA, Varughese, P, Lantvit, DD, Dean, MJ, Burdette, JE. (2021). Silencing PTEN in the fallopian tube promotes enrichment of cancer stem cell-like function through loss of PAX2. Cell Death and Disease, 12, (4). doi:10.1038/s41419-021-03663-2.

Jackson-Bey, T, Colina, J, Isenberg, BC, Coppeta, J, Urbanek, M, Julie Kim, J, Woodruff, TK, Burdette, JE, Russo, A. (2020). Exposure of human fallopian tube epithelium to elevated testosterone results in alteration of cilia gene expression and beating. Human Reproduction, 35, (9), 2086-2096. doi:10.1093/humrep/deaa157.

Fukushiro-Lopes, D, Hegel, AD, Russo, A, Senyuk, V, Liotta, M, Beeson, GC, Beeson, CC, Burdette, J, Potkul, RK, Gentile, S. (2020). Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers. Frontiers in Pharmacology, 11. doi:10.3389/fphar.2020.00577.

Galey, MM, Young, AN, Petukhova, VZ, Wang, M, Wang, J, Salvi, A, Russo, A, Burdette, JE, Sanchez, LM. (2020). Detection of Ovarian Cancer Using Samples Sourced from the Vaginal Microenvironment. Journal of Proteome Research, 19, (1), 503-510. doi:10.1021/acs.jproteome.9b00694.

Salvi, A, Amrine, CSM, Austin, JR, Kilpatrick, KA, Russo, A, Lantvit, D, Calderon-Gierszal, E, Mattes, Z, Pearce, CJ, Grinstaff, MW, Colby, AH, Oberlies, NH, Burdette, JE. (2020). Verticillin A causes apoptosis and reduces tumor burden in high-grade serous ovarian cancer by inducing DNA damage. Molecular Cancer Therapeutics, 19, (1), 89-100. doi:10.1158/1535-7163.MCT-19-0205.

Senyuk, Vitaly, Russo, Angela, Liotta, Margaret, Potkul, Ronald, Beeson, Craig, Burdette, Joanna, Gentile, Saverio. (2020). Repurposing the Kir6.2/SUR2 Channel Activator Minoxidil to Treat Gynecological Cancers. BIOPHYSICAL JOURNAL, 118, (3), 589A-589A.